1–10 of 32 results for Retinitis Pigmentosa
Pericentral Retinitis Pigmentosa
Mauricio Bayram-Suverza, MD
Mark E Pennesi, MD/PhD
Retina Image Bank: Images of the Week
2024
Multicenter Randomized Sham-Controlled Double-Masked Phase 2b Clinical Trial of Multi-Characteristic Opsin in Patients With Advanced Retinitis Pigmentosa
Peter K. Kaiser, MD FASRS
Annual Meeting Talks
2022
One Year Follow-Up in a Phase ½ Clinical Trial of a Gene Modifier Therapy (OCU400) for the Treatment of Retinitis Pigmentosa
Benjamin Bakall, MD, PhD
Updates from the Field
BVA Analysis of Low- or High-Dose MCO-010 Optogenetics Therapy for Retinitis Pigmentosa: First Time 100-Week TOPLINE Results From a Phase 2b/3 Clinical trial (RESTORE)
Michael A. Singer, MD
Subretinal Gene Therapy Drug AGTC-501 for X-Linked Retinitis Pigmentosa: Phase 2 Randomized Controlled Masked Multicenter Clinical Trial (Skyline) Interim Safety Results
On Demand Cases, Courses, and Papers
Double Trouble: Acute Zonal Occult Outer Retinopathy in a Patient With Retinitis Pigmentosa
Dislocated Lens
Scott J Westhouse, DO
2023
Safety and Efficacy of Intravitreal Optogenetic Gene Therapy for Advanced Retinitis Pigmentosa
Sai H Chavala, MD
2021
Tapetoretinal Degeneration
JEFFERSON R SOUSA, Tecg.º (Biomedical Systems Technology)
Clinical Presentantion and Management of Coats-like Exudative Vitreoretinopathy in Retinitis Pigmentosa
Cagri G Besirli, MD, PhD, FASRS
2020